Found 4 results
Author Title [ Type
] Year Filters: Author is Appelbaum, Frederick R [Clear All Filters]
. 2018. “Blood And Marrow Transplant Clinical Trials Network Report On The Development Of Novel Endpoints And Selection Of Promising Approaches For Graft-Versus-Host Disease Prevention Trials.”. Biol Blood Marrow Transplant 24 (6). Biol Blood Marrow Transplant: 1274-1280. doi:10.1016/j.bbmt.2018.01.002.
. 2012. “Comparative Outcomes Of Donor Graft Cd34+ Selection And Immune Suppressive Therapy As Graft-Versus-Host Disease Prophylaxis For Patients With Acute Myeloid Leukemia In Complete Remission Undergoing Hla-Matched Sibling Allogeneic Hematopoietic Cell Transpl”. J Clin Oncol 30 (26). J Clin Oncol: 3194-201. doi:10.1200/JCO.2012.41.7071.
. 2014. “Multicenter Biologic Assignment Trial Comparing Reduced-Intensity Allogeneic Hematopoietic Cell Transplant To Hypomethylating Therapy Or Best Supportive Care In Patients Aged 50 To 75 With Intermediate-2 And High-Risk Myelodysplastic Syndrome: Blood And M”. Biol Blood Marrow Transplant 20 (10). Biol Blood Marrow Transplant: 1566-72. doi:10.1016/j.bbmt.2014.06.010.
. 2015. “Recommendations For Donor Human Leukocyte Antigen Assessment And Matching For Allogeneic Stem Cell Transplantation: Consensus Opinion Of The Blood And Marrow Transplant Clinical Trials Network (Bmt Ctn).”. Biol Blood Marrow Transplant 21 (1). Biol Blood Marrow Transplant: 4-7. doi:10.1016/j.bbmt.2014.09.017.